Results
593
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
593 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
RNDB | US$26.99 | 0.1% | 27.0% | US$140.4m | US$27.00 | PB1.6x | E42.8% | 2.2% | ||
CBMB | US$17.71 | 0.6% | 18.1% | US$58.2m | n/a | PB1.2x | n/a | 5.6% | ||
CNUN | US$40.00 | 0% | n/a | US$52.3m | n/a | PB0.4x | n/a | 5.9% | ||
PTRS | US$7.15 | 1.6% | -20.6% | US$128.5m | n/a | PB0.9x | n/a | 2.2% | ||
SMMF | US$25.70 | -6.4% | 41.2% | US$377.4m | US$30.00 | PB0.9x | E1.5% | 3.4% | ||
MCHB | US$26,000.00 | 0% | n/a | US$1.7b | n/a | PB0.7x | n/a | 5.5% | ||
PRMY | US$23.50 | 2.0% | 7.8% | US$110.6m | n/a | PB1.3x | n/a | n/a | ||
PEBC | US$33.00 | 0% | 13.8% | US$24.1m | n/a | PB0.7x | n/a | 2.5% | ||
FMBM | US$23.38 | -0.4% | 15.5% | US$82.3m | n/a | PB1x | n/a | 4.4% | ||
FCCT | US$8.95 | 0% | -8.8% | US$14.5m | n/a | PB0.8x | n/a | 2.8% | ||
MBKL | US$18.75 | 1.8% | 1.4% | US$38.3m | n/a | PB1x | n/a | 5.3% | ||
OFED | US$12.50 | 0.1% | -3.1% | US$75.9m | n/a | PB1.1x | n/a | 3.2% | ||
MCBK | US$24.75 | 0% | 14.0% | US$64.3m | n/a | PB0.7x | n/a | 1.2% | ||
PBBK | US$15.55 | 1.7% | 26.0% | US$36.7m | n/a | PB0.8x | n/a | n/a | ||
CCBC | US$12.05 | 0.4% | 10.6% | US$38.7m | n/a | PB1x | n/a | n/a | ||
DIMC | US$37.39 | -3.0% | 11.6% | US$94.8m | n/a | PB1x | n/a | 4.3% | ||
MCBI | US$20.98 | -0.05% | 27.2% | US$133.7m | n/a | PB1.1x | n/a | 1.0% | ||
PTBS | US$14.85 | 0.5% | -6.3% | US$61.5m | n/a | PB0.9x | n/a | 3.2% | ||
PBNC | US$41.75 | 0% | -0.6% | US$122.1m | n/a | PB1.1x | n/a | 5.2% | ||
PBCO | US$13.81 | -1.4% | 15.1% | US$71.9m | n/a | PB0.9x | n/a | n/a | ||
BOID | US$31.00 | 0% | n/a | US$108.7m | n/a | PB0.9x | n/a | n/a | ||
CIWV | US$20.26 | 0% | -7.9% | US$35.6m | n/a | PB0.8x | n/a | 4.3% | ||
HLAN | US$144.00 | -3.4% | 69.1% | US$291.1m | US$122.50 | PB1.7x | E-1.2% | 2.1% | ||
VABK | US$41.32 | -1.1% | 29.3% | US$221.8m | n/a | PB1.4x | n/a | 3.2% |